(Q51188891)

1 April 2018

title

The relative efficacy of buspirone, imipramine and placebo in panic disorder: A preliminary report (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

8 January 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

8 January 2023

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

8 January 2023

author name string

D. V. Sheehan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3413203

8 January 2023

A. B. Raj

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3413203

8 January 2023

K. H. Sheehan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3413203

8 January 2023

S. Soto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3413203

8 January 2023

language of work or name

English

0 references

publication date

1 April 1988

1 reference

1 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0091305788902146?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

https://api.elsevier.com/content/article/PII:0091305788902146?httpAccept=text/plain

8 January 2023

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Pharmacology, Biochemistry and Behavior

8 January 2023

published in

1 reference

1 April 2018

volume

29

1 reference

1 April 2018

page(s)

815-817

1 reference

1 April 2018

issue

4

1 reference

1 April 2018

Double-blind comparison of buspirone and clorazepate in anxious outpatients

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Buspirone: review of its pharmacology and current perspectives on its mechanism of action

8 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Buspirone: review of its pharmacology and current perspectives on its mechanism of action

8 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

8 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Comparison of buspirone in two separate studies

8 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Investigation of the abuse liability of buspirone in alcohol-dependent patients.

8 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Acute effects of buspirone and alcohol on psychomotor skills

8 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Review of the side-effect profile of buspirone

8 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Neuropharmacology of Buspirone

8 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Effects of alcohol on buspirone and lorazepam actions

8 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro[4.5]decane-7,9-diones

8 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0091-3057(88)90214-6

8 January 2023

Identifiers

1 reference

1 April 2018

1 reference

1 April 2018